April 09, 2025 article Open access CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses Science Advances DOI: 10.1126/sciadv.adq4297 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 2 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure 2022 OncoImmunology article Medicine CAR-T cell therapy research Open access cited by 2 patents 60 citations T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes 2021 Nature Biotechnology article Medicine CAR-T cell therapy research Open access cited by 7 patents 36 citations Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma 2023 Blood Advances article Medicine CAR-T cell therapy research Open access 19 citations High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs 2023 Journal of Biological Chemistry article Immunology and Microbiology T-cell and B-cell Immunology Open access 9 citations 4 results